In one widely cited study, Dihexa restored cognitive performance in a rat model of Alzheimers to near-normal levels outperforming donepezil (Aricept), a standard FDA-approved Alzheimers treatment
A plausible scenario, then, looks like this: Phase 3 primary completion in late 2025, NDA submission in the second half of 2025, FDA filing acceptance and review initiation in early 2026, and a PDUFA (Prescription Drug User Fee Act) action date likely in mid to late 2026
How long does Wegovy take to work and deliver real results
The Precision Peptide Genetic Test from PlexusDx can help identify whether your GLP1R genetic variants (like rs6923761) predispose you to stronger appetite control on GLP-1 therapy, suggesting you may benefit more from extended treatment
Ever since GLP-1s started getting attention as weight loss drugs, interested seniors have been forced to choose between their weight and their pocketbooks
JFRB Med